You will hear plenty of commentary from Fitbit (FIT) fans and investors regarding the future of Fitbit with a focus on the company evolving or spiriting products for the healthcare industry. Of course, this is exactly what Fitbit desires from investor sentiment as the company witnesses its sales in the consumer industry nearing saturation in many regions around the world….
Fitbit And Medtronic: Headlines Vs. Reality
A financial market resource for the every-day investor and trader.
-
Marko Kolanovic/J.P. Morgan 2020 Outlook
Seth Golden, , Research Reports, 0
MACROECONOMIC OUTLOOK: Our view is that the market turmoil and economic slowdown over the past 18 months is not...
-
Target May Have Beaten Expectations, But Inventory Reductions Loom Large With Investors
Seth Golden, , Research Reports, 0
Back in March of 2017, I authored an article that focused on all that has been ailing Target Corp....
-
Weekly State of the Market: Peak Yields, Dollar?
Seth Golden, , Research Reports, 0
“Do you know what investing for the long run, but listening to market news everyday is like? It’s like...
-
Volatility Crunched, But Rising Rate Fears Remain
Seth Golden, , Research Reports, 0
The major indexes posted slight weekly losses last week. The Dow and S&P 500 both fell 0.5% for the...
-
The Leuthold Group: Inflation: Bank Run Edition
Seth Golden, , Research Reports, 0
The non-seasonally adjusted headline CPI eased for an eighth consecutive month to 6.0% in February (Chart 1). The seasonally...
-
Assessing and Addressing The Market Season
Seth Golden, , Research Reports, 0
We’re back! It has been a couple of weeks since our last weekly Research Report, but we hope some...
-
Merrill Lynch: The Great New Dawn Era (2022 and beyond)
Seth Golden, , Research Reports, 0
Macro Strategy—No Respite For The Weary: After two years of a pandemic, the world now has to deal with...
-
Morgan Stanley: At Year-End, Don’t Be Late
Seth Golden, , Research Reports, 0
Don’t be late. Life often throws us curve balls and when it does,all we can do is adjust our...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00